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ABSTRACT 
Many human cancer cells contain more than two centrosomes, yet these cancer cells can 
form pseudo-bipolar spindles through the mechanism, called centrosome clustering, and 
survive, instead of committing lethal multipolar mitoses. Kinesin-14/HSET, a minus end-
directed motor, plays a crucial role in centrosome clustering. Accordingly, HSET is 
deemed to be a promising chemotherapeutic target to selectively kill cancer cells. 
Recently, three HSET inhibitors (AZ82, CW069 and SR31527) have been reported, but 
their specificity and efficacy have not been evaluated rigorously. This downside partly 
stems from the lack of robust systems for the assessment of these drugs. Yeasts and 
filamentous fungi provide not only powerful models for basic and applied biology but 
also versatile tools for drug discovery and evaluation. Here we show that these three 
inhibitors on their own are cytotoxic to fission yeast, suggesting that they have off-targets 
in vivo except for kinesin-14. Nonetheless, intriguingly, AZ82 can neutralize otherwise 
toxic overproduced HSET; this includes a substantial reduction in the percentage of 
HSET-driven abnormal mitotic cells and partial suppression of its lethality. SR31527 also 
displays modest neutralizing activity, while we do not detect such activity in CW069. As 
an experimental proof-of-principle study, we have treated HSET-overproducing fission 
yeast cells with extracts prepared from various plant species and found activities that 
rescue HSET-driven lethality in those from Chamaecyparis pisifera and Toxicodendron 
trichocarpum. This methodology of protein overproduction in fission yeast, therefore, 
provides a convenient, functional assay system by which to screen for not only selective 
human kinesin-14 inhibitors but also those against other molecules of interest. 
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1. INTRODUCTION 
Most animal cells have two centrosomes from which mitotic bipolar spindles assemble. 
This bipolarity is essential for equal segregation of genetic material, thereby ensuring 
genome stability. Like DNA duplication, a cell has a robust regulatory mechanism by 
which centrosome number is maintained strictly as one or two copies per cell, which 
orchestrates the chromosome cycle (Conduit et al., 2015; Fu et al., 2015). Interestingly, 
it is known that in many cancer cells, this synchrony between centrosome and 
chromosome cycles becomes uncoupled, by which such cells contain more than two 
centrosomes. Nonetheless, these cancer cells appear to divide normally by means of 
bipolar spindles without undergoing lethal multipolar mitoses (Quintyne et al., 2005). It 
has been shown that these cells could form pseudo-bipolar spindles by clustering the 
supernumerary centrosomes into two poles (Cosenza and Kramer, 2016; Gergely and 
Basto, 2008). Perturbations in centrosome clustering trigger multipolar spindle formation 
and mitotic catastrophe specifically in cancer cells with supernumerary centrosomes 
(Kwon et al., 2008; Quintyne et al., 2005).  
 Centrosome clustering is achieved by a side-by-side, rather than dispersed, 
positioning of individual centrosomes; this configuration results in the formation of two 
spindle poles that is facilitated through a microtubule-dependent inward force. 
Accordingly, a variety of cellular processes affecting microtubule-based tension and 
motility are involved in the clustering of supernumerary centrosomes (Godinho et al., 
2009; Kramer et al., 2011; Leber et al., 2010; Rhys et al., 2018).  
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 One of the crucial factors required for centrosome clustering is human 
HSET/KIFC1. This protein is a member of the kinesin-14 family of proteins that includes 
mouse Kifc2, Xenopus XCTK2, Drosophila Ncd, C. elegans KLP-15, Arabidopsis ATK5 
and KCBP, Aspergillus KlpA, fission yeast Pkl1 and Klp2 and budding yeast Kar3 
(Ambrose et al., 2005; Endow and Komma, 1996; Goshima and Vale, 2005; Hanlon et 
al., 1997; Meluh and Rose, 1990; O'Connell et al., 1993; Paluh et al., 2000; Robin et al., 
2005; Saito et al., 1997; Troxell et al., 2001; Walczak et al., 1998; Yukawa et al., 2018). 
Kinesin-14 motor proteins have minus-end directionality and comprise three functional 
domains, an N-terminal tail domain, a central coiled-coil stalk domain and a C-terminal 
motor domain that possesses the ATPase activity (She and Yang, 2017). It is reported that 
HSET is abundantly expressed in several cancer cell lines including ovary, breast and 
lung cancer (Grinberg-Rashi et al., 2009; Pannu et al., 2015; Pawar et al., 2014). 
Intriguingly, knockdown of HSET in supernumerary centrosome-containing breast 
cancer cell lines prevents centrosome clustering and induces cell death by multipolarity 
in anaphase, while in normal cell lines that contain two centrosomes this treatment does 
not result in lethality (Kleylein-Sohn et al., 2012; Kwon et al., 2008). Therefore, specific 
targeting of HSET may provide a novel strategy by which to selectively kill cancer cells 
(Li et al., 2015; Xiao and Yang, 2016).  
To date, three HSET inhibitors, designated AZ82, CW069 and SR31527 have 
been reported (Cosenza and Kramer, 2016; Watts et al., 2013; Wu et al., 2013; Xiao and 
Yang, 2016; Zhang et al., 2016) (Table 1). AZ82, which is the first HSET inhibitor to be 
identified, binds specifically to the HSET-microtubule binary complex, thereby inhibiting 
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the microtubule-stimulated ATPase activity of HSET (Park et al., 2017; Wu et al., 2013; 
Yang et al., 2014). Upon addition to cancer cells with supernumerary centrosomes, this 
small molecule inhibitor triggers multipolar spindle formation and mitotic catastrophe. 
The second inhibitor, CW069, was designed and synthesized according to in silico 
computational modeling for HSET binding (Watts et al., 2013). This compound binds to 
HSET in an allosteric manner and reduces its ATPase activity in vitro. While cells treated 
with monastrol, a kinesin-5 inhibitor, exhibit mitotic arrest with monopolar spindles, co-
treatment with CW069 suppresses monopolarity induced by monastrol. CW069 also 
induces multipolar mitoses in cells containing supernumerary centrosomes (Watts et al., 
2013). Finally, SR31527 was identified through a high-throughput screen based on an 
ATPase assay of HSET (Zhang et al., 2016). It inhibits HSET by binding directly to a 
novel allosteric site within the motor domain without involving microtubules. SR31527 
reportedly prevents bipolar clustering of extra centrosomes in triple-negative breast 
cancer (TNBC) cells, and significantly reduces viability of TNBC cells. Despite the 
developments of these HSET inhibitors, their biological efficacy and off-target toxicity 
have not been evaluated properly, which is a crucial step towards clinical implementation 
of these drugs. 
The fission yeast, Schizosaccharomyces pombe, has provided an excellent system 
not only as a model organism for basic biology but also as a useful tool for drug discovery 
and its assessment (Benko et al., 2016; Herrero et al., 2006; Lewis et al., 2017). Previously, 
we showed that HSET, when overexpressed in fission yeast, is toxic, and leads to mitotic 
arrest with monopolar spindles, reminiscent of overproduction of fission yeast kinesin-
 6 
14, Pkl1 or Klp2 (Yukawa et al., 2018). In this study, we have attempted to exploit this 
phenotype for the functional evaluation of the three known HSET inhibitors described 
earlier. We have found that all these reagents have HSET-independent cytotoxicity on 
fission yeast growth, indicating that they may not be specific to HSET. Intriguingly, 
however, AZ82 displays neutralizing activity against HSET-induced lethality. 
Furthermore, by applying this assay system to natural sources, we have identified HSET-
suppressing activities in extracts prepared from plant species. 
 
2. MATERIALS AND METHODS 
2.1 Strains, media, and genetic methods  
Fission yeast strains used in this study are listed in Table 2. Media, growth conditions, 
and manipulations were carried out as previously described (Bähler et al., 1998; Moreno 
et al., 1991; Sato et al., 2005). For most of the experiments, rich YE5S liquid media and 
agar plates were used. Wild-type strain (513; Table 2), drug-sensitive strains (YA8 and 
SAK931) were provided by P. Nurse (The Francis Crick Institute, London, England, UK), 
M. Yoshida (Chemical Genetics Laboratory, RIKEN, Saitama, Japan) and S. A. 
Kawashima (Graduate School of Pharmaceutical Sciences, The University of Tokyo, 
Tokyo, Japan), respectively. For overexpression experiments using thiamine-repressible 
nmt series plasmids (Basi et al., 1993; Maundrell, 1990), cells were first grown overnight 
in Pombe Glutamate Medium (PMG, the medium in which the ammonium of EMM2 is 
replaced with 20 mM glutamic acid) with the required amino acid supplements in the 
presence of 15 µM thiamine. Thiamine was then washed out by filtration pump and cells 
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continued to be cultured in the same PMG media in the absence of thiamine for further 
12-48 h as necessary. For spot tests, these cells were serially diluted 10-fold, from an 
initial concentration of 2 x 107 cells/ml, and spotted onto PMG plates with added 
supplements in the presence or absence of 15 µM thiamine. Plates were incubated at 27°C 
or 30°C.  
2.2 Preparation and manipulation of nucleic acids  
Enzymes were used as recommended by the suppliers (New England Biolabs Inc. Ipswich, 
MA and Takara Bio Inc., Shiga, Japan). 
2.3 Chemical compounds 
AZ82 was supplied from AstraZeneca (Boston, MA, U.S.A.). CW069 was a kind gift of  
S. V. Ley, the University of Cambridge. SR31527 was purchased from Vitas-M 
Laboratory (Apeldoorn, The Netherlands; Cat number: STK400735). All chemicals were 
dissolved in DMSO at 10 mM and stored at −20°C. 
2.4 Treatment of HSET-overproducing fission yeast cells with kinesin 14 inhibitors 
Cells were cultured in YE5S or PMG liquid media with the required amino acid 
supplements and thiamine until mid-log phase at 30°C. Thiamine was washed out and 
cells shifted to the same PMG liquid media without thiamine at a concentration of 1 × 105 
cells/ml. The kinesin-14 inhibitors or DMSO (mock) were then added at various 
concentrations between 1 µM and 100 µM (0.01%–1% DMSO solution) and the cells 
were cultured at 30°C. OD measurements for yeast cultures were performed in a 
microplate reader (CHROMATE 4300; Awareness Technology Inc., Palm City, FL, 
U.S.A.), using an Iwaki Round Bottom 96-well microplate with lid and 200 µl per well 
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for all measurements. OD measurements were performed at 600 nm at 30°C. Yeast cell 
number was determined using an automated cell counter (F-820; Sysmex, Kobe, Japan). 
Images of culture were taken by FAS-IV gel imaging system (Nippon Genetics, Tokyo, 
Japan). 
2.5 Preparation of plant extracts and assay for HSET-neutralizing activity 
Extracts from plant species were prepared with standard procedures as previously 
described (Kimura et al., 2012) and dissolved in methanol (10 mg/ml). Minimal plates 
without thiamine were made by adding 50 ml of agar media containing fission yeast cells 
that overproduced HSET (4.6 x 104 cells/ml). Upon a series of 2-fold dilutions, 5 µl 
extracts were spotted onto these plates. Plates were then incubated at 28°C for 3 d. 
2.6 Fluorescence microscopy 
Fluorescence microscopy images were obtained using a DeltaVision microscope system 
(DeltaVision Elite; GE Healthcare, Chicago, IL, U.S.A.) comprising a wide-field inverted 
epifluorescence microscope (IX71; Olympus, Tokyo, Japan) and a Plan Apochromat 60×, 
NA 1.42, oil immersion objective (PLAPON 60×O; Olympus Tokyo, Japan). DeltaVision 
image acquisition software (softWoRx 6.5.2; GE Healthcare, Chicago, IL) equipped with 
a charge-coupled device camera (CoolSNAP HQ2; Photometrics, Tucson, AZ, U.S.A.) 
was used. Live cells were imaged in a glass-bottomed culture dish (MatTek Corporation, 
Ashland, MA, U.S.A.) coated with soybean lectin and incubated at 27°C. To keep cultures 
at the proper temperature, a temperature-controlled chamber (Air Therm SMT; World 
Precision Instruments Inc., Sarasota, FL, U.S.A.) was used. Images were taken as 14–16 
sections along the z axis at 0.2 µm intervals; they were then deconvolved and merged into 
 9 
a single projection. The sections of images acquired were compressed into a 2D projection 
using the DeltaVision maximum intensity algorithm. Deconvolution was applied before 
the 2D projection. Captured images were processed with Photoshop CS6 (version 13.0; 
Adobe, San Jose, CA, U.S.A.). 
2.7 Statistical data analysis 
We used the two-tailed χ2 test to evaluate the significance of differences between 
frequencies of the cells with bipolar spindles in different strains. We used this key for 
asterisk placeholders to indicate p-values in the figures: e.g., ****, P < 0.0001. For growth 
curve experiments, the results are expressed as the mean ± standard error of the mean 
(SE). 
 
3. RESULTS 
3.1 The lethality of fission yeast cells overproducing HSET/kinesin-14 is rescued by 
co-overproduction of Cut7/kinesin-5 
Bipolar spindle assembly requires proper force-balance generated by kinesin-5 and 
kinesin-14 (Sharp et al., 2000; She and Yang, 2017; Tanenbaum and Medema, 2010). In 
fission yeast, ectopic overproduction of kinesin-14 Pkl1 or inactivation of kinesin-5 Cut7 
results in force imbalance leading to mitotic arrest with monopolar spindles (Hagan and 
Yanagida, 1990; Pidoux et al., 1996; Yukawa et al., 2018). Interestingly, mitotic arrest 
caused by Pkl1 overproduction is neutralized by co-overproduction of Cut7 and that cells 
overproducing both kinesins are capable of forming colonies (Rincon et al., 2017) 
(bottom two rows in Fig. 1A). 
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We previously showed that overexpression of another kinesin-14, Klp2 or human 
HSET, is also lethal in fission yeast cells with a similar monopolar spindle phenotype 
(Yukawa et al., 2018). Therefore, we asked whether such Cut7-dependent rescue seen in 
Pkl1 overproducing cells is also observed in the case of overproduction of HSET or Klp2. 
As expected, Cut7 co-overproduction effectively suppressed the lethality of cells 
overproducing HSET or Klp2 (Fig. 1A and B). Observation of spindle morphology 
showed that while cells overproducing only Pkl1 or HSET displayed a high frequency of 
monopolar spindles (82%, n=151 or 85%, n=39 respectively), in those co-overproducing 
Pkl1 and Cut7 or HSET and Cut7, the frequency was substantially reduced to 12% (n=49) 
or 45% (n=38) respectively (Fig. 1C and D). Hence, HSET (and Klp2) is capable of 
generating inward pulling forces, thereby antagonizing outward pushing forces exerted 
by Cut7. 
3.2 An assay system for evaluation of human kinesin-14 inhibitors using fission yeast  
Yeast-based screening for biologically active small molecules has successfully been 
implemented for the identification of promising drugs against human cancer and other 
diseases (Mager and Winderickx, 2005). This strategy is also useful to develop reagents 
that exhibit a beneficial impact on normal cells, e.g. those promoting lifespan extension 
(Sarnoski et al., 2017). Fission yeast has been used for several screenings, such as 
purification of specific compounds produced by Actinomycetes (Lewis et al., 2017) and 
a functional assay for Indinavir, an inhibitor against Human Immunodeficiency Virus 
Type-1 (Benko et al., 2016; Benko et al., 2017; Yang et al., 2012). Having seen toxicity 
derived from overproduced HSET in fission yeast cells (see Fig. 1A), we exploited this 
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lethal phenotype for the biological evaluation of known HSET inhibitors described earlier 
(AZ82, CW069 and SR31527) (Cosenza and Kramer, 2016; Xiao and Yang, 2016; Watts 
et al., 2013; Wu et al., 2013; Zhang et al., 2016). 
Since we can detect the inhibitory activity of compounds through a simple assay 
for cell growth properties, it is possible to assess the specificity and the efficacy of these 
inhibitors. If inhibitors were truly specific to HSET molecules, these compounds on their 
own would not make any adverse impact on fission yeast growth (top row in Fig. 2A, 
referred to as specific drugs). Upon overexpression of HSET, these inhibitors would now 
ameliorate viability loss resulting from HSET-mediated toxicity (bottom two rows in Fig. 
2A). By contrast, if these small molecules could not inhibit HSET activity, viability would 
not be increased in their presence (second row in Fig. 2A). 
On the other hand, if inhibitors on their own interfere with fission yeast growth, 
it implies that these compounds recognize molecules or inactivate some pathways that 
are essential for fission yeast cells independent of HSET; in other words, these inhibitors 
are not specific to HSET, but instead they are drugs that exhibit off-target effects (top 
row in Fig. 2B, referred to as multi-target drugs). Nonetheless, if HSET is effectively 
inhibited by these drugs, viability of fission yeast cells would be ameliorated to some 
extent compared to that without drug treatment (bottom row in Fig. 2B). Alternatively, if 
drugs’ inhibitory activity is weaker, the degree of viability loss would not be additive 
when drug treatment and HSET overproduction are applied in combination compared to 
that under each condition (second row from the bottom in Fig. 2B). 
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3.3 All three known HSET inhibitors have non-specific cytotoxicity toward fission 
yeast cells 
As aforementioned, if the HSET inhibitors were specific to human kinesin-14, addition 
of these molecules to wild type fission yeast should not incur any adverse effects on cell 
growth, as there are no targets (i.e. HSET) in these cells. Even if these reagents were to 
cross-inhibit fission yeast kinesin-14 molecules (i.e. Pkl1 and Klp2), they would not kill 
fission yeast cells, as deletion of either pkl1 or klp2, or even double deletion is viable 
(Troxell et al., 2001). 
To address the specificity of HSET inhibitors, we first treated wild type fission 
yeast cells individually with these drugs without introducing HSET. As shown in Fig. 3 
(top row), AZ82 inhibited cell growth, while CW069 and SR31527 had no deleterious 
impact on growth curve, though SR31527 displayed a marginal inhibitory effect. It is 
known that wild type yeast cells are often inherently resistant to various exogenously 
added drugs. This multi-drug resistance can mainly be attributed to two reasons. One is 
that a thick cell wall prevents drugs entering the cells, and the other is that the presence 
of P-glycoprotein transporters actively pumps out incorporated drugs from the cells to the 
media (Nishi et al., 1992). Therefore, it is common in yeast studies to use drug-sensitive 
strains for this type of chemical biology (Aoi et al., 2014; Arita et al., 2011; Kawashima 
et al., 2012; Kawashima et al., 2013). Given this situation, we next exploited two 
genetically tractable strains that are specifically designed for a drug assessment (YA8 and 
SAK931, Table 2) (Kawashima et al., 2012; Kawashima et al., 2013; Takemoto et al., 
2016). In these strains, genes involved in influx and efflux of exogenously added drugs 
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are multiply deleted; in YA8, genes encoding two major ATP-binding cassette (ABC) 
family transporters, Bfr1 and Pmd1, are deleted (bfr1∆pmd1∆) (Arita et al., 2011), while 
SAK931 contains deletions of 5 additional genes (7∆) (Takemoto et al., 2016). These 5 
genes encode the major facilitator superfamily (MFS) transporters Caf5 and Mfs1, a P-
type ATPase Dnf2, a C-22 sterol desaturase Erg5 and an AP-1-like transcription factor 
Pap1 (Aoi et al., 2014; Takemoto et al., 2016). While Caf5, Dnf2, Erg5 and Mfs1 inhibit 
influx and/or promote efflux of exogenously added drugs at the plasma membrane or the 
endoplasmic reticulum in collaboration with Bfr1 and Pmd1 (Kawashima et al., 2012; 
Kawashima et al., 2013; Takemoto et al., 2016), nuclear-localizing Pap1 regulates 
transcription of a wide range of genes involved in drug resistance (Toda et al., 1992; Toda 
et al., 1991; Toone et al., 1998). 
As shown in Fig. 3 (bottom row), we found that all three drugs now displayed 
very strong growth-inhibitory effects on YA8 or SA931 at 100 µM. CW069 was not 
cytotoxic in YA8 cells, but was in SAK931; fission yeast cells are likely less permeable 
to CW069 than AZ82 or SR31527. These results indicated that all three HSET inhibitors 
targeted molecules besides HSET within fission yeast cells that are essential for cell 
viability. It is noted that no obvious alterations in cell morphology were observed as a 
result of treatment with these drugs (Lewis et al., 2017), of which currently, the molecular 
details of cytotoxicity remain to be dissected. In summary, we conclude that none of the 
three inhibitors examined is indisputably specific to HSET, but instead these small 
molecules interfere with unknown molecular pathways that are needed for cell viability 
of fission yeast.   
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3.4 AZ82 modestly rescues the lethality caused by HSET overproduction 
We next sought to address whether these inhibitors are capable of rescuing the lethality 
of fission yeast cells resulting from forced expression of HSET. For this purpose, we 
assessed the number of cells in the presence or absence of inhibitors upon HSET 
overproduction. As the three kinesin-14 inhibitors displayed HSET-independent 
cytotoxicity (see Fig. 3), various concentrations of individual drugs were tested in YA8 
and SAK931 cells to find optimal concentrations which would, on one hand, repress 
HSET-mediated lethality, and yet, on the other hand, display minimal cytotoxicity on 
their own. Intriguingly, we found that 10 µM AZ82 could rescue the lethality caused by 
HSET overproduction in YA8 cells (~3 fold increase of viability; 6% vs 17% in the 
absence and presence of AZ82 respectively, Fig. 4A and B). As the viability of cells 
treated with AZ82 alone dropped to 47%, the degree of rescue by AZ82 would be larger 
than 3 fold. We also examined microtubule structures in HSET-overproducing cells in 
the presence or absence of AZ82. Interestingly, consistent with growth recovery, HSET-
overproducing cells treated with AZ82 exhibited the lower percentage of mitotic cells 
containing monopolar spindles (54% in the absence of AZ82 and 28% or 6% in the 
presence of 10 µM or 15 µM AZ82, respectively, Fig. 4C). 
By contrast, neither CW069 or SR31527 exhibited noticeable recovery of cell 
viability at any concentrations examined (Fig. 4A and B). Nonetheless, it is noteworthy 
that no additive toxicity was observed between SR31527 and HSET overproduction, 
inviting the possibility that SR31527 also neutralized HSET-mediated lethality (see Fig. 
2B), albeit in a somewhat modest manner. As for CW092, as far as we are concerned, we 
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failed to detect any HSET-neutralizing activity when assayed using the fission yeast 
system. Taking these results together, we consider that AZ82 and to a lesser extent 
SR31527 as well can block HSET function in fission yeast, although they possess off-
target effects (Table 3). 
3.5 Identification of activities in plant extracts that neutralize toxicity derived from 
HSET overproduction 
As a first step towards proof-of-principal studies, we next sought to discover activities 
derived from natural products that can rescue HSET-mediated lethality (Fig. 5A). For this 
purpose, we used extracts that were prepared from various plants. As shown in Fig. 5B, 
we found such neutralizing activities in extracts prepared from Chamaecyparis pisifera 
(Sawara cypress, a species of false cypress) and Toxicodendron trichocarpum (Japanese 
sumac, an Asian tree species of genus Toxicodendron). Hence, the methodology 
developed in this study will be a versatile tool for the discovery of novel HSET inhibitors. 
It is, however, of note that although it was evident that the addition of extracts prepared 
from Chamaecyparis pisifera or Toxicodendron trichocarpum promoted growth of 
otherwise lethal HSET-overproducing cells, the growth inhibitory zone appeared in the 
middle of the spot (0.4 µg, Fig. 5B). This implied either that extracts contained two 
separate activities (HSET-neutralizing and cytotoxic towards fission yeast cells) or that 
these two activities were derived from the same compound as shown earlier for AZ82 
(see Fig. 4B). Further characterization of these extracts, including biochemical 
fractionation and purification, is needed.  
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4. DISCUSSION 
In this study, we have introduced a novel, simple assay system using fission yeast that 
enables us to monitor the specificity and efficacy of known inhibitors against human 
kinesin-14 proteins. Recently, much attention has been attracted to mitotic kinesins as 
novel antitumor targets and several kinesin inhibitors including those used in this study 
have been developed as potential cancer therapeutics (Al-Obaidi et al., 2016; Cosenza 
and Kramer, 2016; Huszar et al., 2009; Ma et al., 2014; Ohashi et al., 2015; Xiao and 
Yang, 2016). Among them, human kinesin-14 inhibitors are regarded to be promising, as 
many cancer cells display dysregulation of the centrosome cycle, resulting in the 
emergence of supernumerary centrosomes. Yet, these cells escape from lethal 
multipolarity, which is attributed to HSET-dependent centrosome clustering (Cosenza 
and Kramer, 2016; Gergely and Basto, 2008; Kwon et al., 2008). These drugs are 
expected to have minimal impact on non-transformed cells, as HSET is not essential for 
normal mitosis in human beings. Consistent with this notion, all three HSET inhibitors 
(AZ82, CW069 and SR31527) have been shown to inhibit motor activities of HSET in 
vitro and display growth-suppressing characteristics to some extent in human cancer cells 
that contain supernumerary centrosomes (Watts et al., 2013; Wu et al., 2013; Zhang et al., 
2016). However, whether these drugs are specific to HSET has not rigorously been 
evaluated. One reason for this pitfall is that depletion or inactivation of HSET, a target of 
these drugs, in tumor cells results in low viability, which hampers accurate assessment of 
off-target effects in these cells. 
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Given this complication, the fission yeast system introduced in this work is robust. 
As fission yeast cells are devoid of HSET, the existence of off-target effects are easily 
monitored and reliably assessed. Our results indicate that all three drugs have undesirable 
targets in fission yeast that are essential for cell viability. Accordingly, we ponder that in 
principle, none of these reagents is ideal as a specific HSET inhibitor. It is of note that 
consistent with this proposition, the existence of target molecules other than HSET was 
previously pointed out for all three drugs (Watts et al., 2013; Wu et al., 2013; Zhang et 
al., 2016). 
Despite HSET-independent cytotoxic effects, we have found that AZ82 exhibits 
inhibitory activity toward otherwise lethal HSET overproduction in fission yeast and that 
SR31527 is likely to neutralize toxicity resulting from HSET overproduction, although 
their impact is less than that of AZ82. As we are able to monitor the specificity and the 
efficacy of HSET inhibitors by implementing this system, if new inhibitors were 
developed, our rapid and robust strategy would provide a powerful tool for their 
biological assessment in combination with a conventional human culture cell system.   
In fission yeast, as in other organisms, simultaneous inactivation of kinesin-5 and 
kinesin-14 rescues lethality resulting from kinesin-5 inhibition alone (Civelekoglu-
Scholey et al., 2010; Mountain et al., 1999; O'Connell et al., 1993; Pidoux et al., 1996; 
Rincon et al., 2017; Rodriguez et al., 2008; Saunders et al., 1997; Troxell et al., 2001; 
Wang et al., 2015; Yukawa et al., 2017; Yukawa et al., 2018). Thus, effective inhibitors 
against fission yeast kinesin-14s (Pkl1 and Klp2) could be identified using cut7 
temperature-sensitive mutants, as previously proposed in the Aspergillus nidulans system 
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(Wang et al., 2015). These inhibitors might also be effective to suppress HSET activities, 
as HSET and Pkl1/Klp2 are structurally conserved and HSET functionally replaces for 
Pkl1 or Klp2 when introduced into fission yeast (Yukawa et al., 2018). 
Finally, we would like to point out that the methodology described in this study 
could be exploited as an assay system for inhibitors against any human proteins of interest. 
Provided that overproduction of those human proteins display some defective phenotypes 
including lethality, which is often the case (Benko et al., 2017; Matsuyama et al., 2006; 
Nkeze et al., 2015), small molecule libraries, natural products or extracts from any 
organism could be used to identify potential inhibitors (Fig. 5A). In fact, we have detected 
activities derived from Chamaecyparis pisifera (Sawara cypress) and Toxicodendron 
trichocarpum (Japanese sumac) that specifically rescued lethality caused by HSET 
overproduction (Fig. 5B). Detailed characterization of these molecules is in progress 
using both fission yeast and human cancer cells. 
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Table 1: IC50 of HSET/KIFC1 inhibitors 
 
 
 
 
 
 
Microtubule-stimulated ATPase activity was measured using bacterially-produced HSET 
proteins. Viability was measured using cancer cell lines that contain excess centrosomes. 
Values (µM) are taken from the following references: AZ82 (Wu et al., 2013); SR31527 
(Zhang et al., 2016); CW069 (Watts et al., 2013). N.D., not determined. 
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Table 2: Fission yeast strains used in this study 
Strains Genotypes 
Figures 
used 
Derivations 
TY206 h− aur1R-Pnda3-mCherry-atb2 leu1 ura4 1A, 1D This study 
TY223 
h+ kanR-Pnmt41-cut7 aur1R-Pnda3-mCherry-atb2 leu1 
ura4 his2 
1A, 1D This study 
MY1212 
h− lys1+-Pnmt41-GFP-HSET aur1R-Pnda3-mCherry-
atb2 leu1 ura4 lys1 
1A, 1C-
D 
This study 
TY241 
h− kanR-Pnmt41-cut7 lys1+-Pnmt41-GFP-HSET aur1R-
Pnda3-mCherry-atb2 leu1 ura4 lys1 
1A, 1C-
D 
This study 
MY1230 
h− lys1+-Pnmt1-GFP-pkl1 aur1R-Pnda3-mCherry-atb2 
leu1 ura4 lys1 
1A, 1C-
D 
This study 
TY245 
h− kanR-Pnmt41-cut7 lys1+-Pnmt1-GFP-Pkl1 aur1R-
Pnda3-mCherry-atb2 leu1 ura4 lys1 
1A, 1C-
D 
This study 
TY208 h− leu1 ura4 [pREP41-GFP] 1B This study 
TY212 h− kanR-Pnmt41-cut7 leu1 ura4 [pREP41-GFP] 1B This study 
TY211 h− leu1 ura4 [pREP41-GFP-klp2] 1B This study 
TY215 h− kanR-Pnmt41-cut7 leu1 ura4 [pREP41-GFP-klp2] 1B This study 
513 h− leu1 ura4 3 
Our 
laboratory 
stock 
YA8 h+ bfr1::ura4+ pmd1::hisG leu1 ura4 3, 4A 
(Arita et al., 
2011) 
SAK931 
h− caf5::bsdR pap1Δ pmd1Δ mfs1Δ bfr1Δ dnf2Δ 
erg5::ura4+ leu1 ura4 ade6-M210 
3 
(Takemoto 
et al., 2016) 
MY1204 
h− lys1+-Pnmt1-HSET bfr1::ura4+ pmd1::hisG aur1R-
Pnda3-mCherry-atb2 leu1 ura4 lys1 
4A This study 
TY250 
h− caf5::bsdR pap1Δ pmd1Δ mfs1Δ bfr1Δ dnf2Δ 
erg5::ura4+ leu1 ura4 ade6-M210 
 [pREP41-GFP] 
4A-B This study 
TY247 
h− caf5::bsdR pap1Δ pmd1Δ mfs1Δ bfr1Δ dnf2Δ 
erg5::ura4+ leu1 ura4 ade6-M210 
 [pREP41-GFP-HSET] 
4A-B This study 
TY26 h+ bfr1::ura4+ pmd1::hisG leu1 ura4 [pREP41-GFP] 4B This study 
TY27 
h+ bfr1::ura4+ pmd1::hisG leu1 ura4 [pREP41-GFP-
HSET] 
4B-C, 
5B 
This study 
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Table 3: Effects of HSET/KIFC1 inhibitors in fission yeast 
 
  
 
 
 
 
AZ82 is toxic to all three fission yeast strains tested (513: wild type; YA8: bfr1∆pmd1∆; 
SAK931: 7∆). CW069 is toxic only to SAK931, while SR31527 is toxic to YA8 and 
SAK931. 
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LEGENDS FOR FIGURES 
Fig. 1: Co-overproduction of kinesin-5 Cut7 neutralizes growth toxicity derived 
from kinesin-14 overproduction 
(A, B) Spot test. Strains overexpressing cut7 (cut7oe) and/or a gene encoding kinesin-14 
(A, fission yeast pkl1oe or human HSEToe or B, fission yeast klp2oe) were serially (10-fold) 
diluted, spotted onto minimal plates in the presence or absence of thiamine 
(+Thi/repressed or –Thi/derepressed, respectively) and incubated at 30°C for 3 d. cell 
conc., cell concentration. klp2 was expressed ectopically on plasmids. nmt1-pkl1 and 
nmt41-HSET were integrated at the lys1 locus (Yukawa et al., 2018), while the nmt41 
promoter was integrated in front of the initiation codon of the cut7 gene (Bähler et al., 
1998). (C) Cellular localization of overexpressed Pkl1 and HSET and spindle 
morphology. Representative images are shown for each strain. Scale bars, 10 µm. (D) 
The percentage of bipolar (green) or monopolar spindles (magenta) upon overexpression 
of either pkl1 or HSET. In each condition, more than 30 mitotic cells were counted (n>30). 
All p-values are derived from the two- tailed χ2 test (***P<0.001; ****P<0.0001). 
 
Fig. 2: Strategy for evaluation of the specificity and efficacy of human kinesin-14 
inhibitors using a fission yeast system 
Inhibitors against human kinesin-14 are categorized into two classes. The first class is 
those that do not inhibit fission yeast cells on their own (A, specific drugs). The second 
class is those that possess growth-inhibiting activities on their own. It is likely that these 
drugs have some target molecules other than HSET that are essential for fission yeast cell 
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viability (B, multi-target drugs). In either type A or B, we could assess inhibitory activity 
toward HSET by monitoring growth properties of cells in which HSET is overproduced 
in the presence or absence of drug treatment. 
 
Fig. 3: The three kinesin-14 inhibitors display off-target cytotoxicity in fission yeast 
Growth suppression of fission yeast cells upon treatment with individual kinesin-14 
inhibitors. Wild type (513, Table 2) (top row) and two types of drug-permeable fission 
yeast strains (YA8: bfr1∆pmd1∆ or SAK931: 7∆, Table 2) were used (bottom row). Error 
bars (SE) are calculated from at least 2 independent experiments.  
 
Fig. 4: AZ82 partially rescues HSET-induced lethality 
(A) Growth characteristics of fission yeast cells upon HSET overproduction in the 
presence of individual inhibitors. YA8 (top) or SA931 cells (bottom) overexpressing the 
HSET gene were inoculated at 105 cells/ml in minimal medium in the absence of thiamine 
(derepressed condition, ON) in 96-hole microplates, and DMSO (mock) or drug 
(dissolved in DMSO) was added. The final concentration of DMSO was 1%. Cells were 
incubated for 2-3 d at 30°C. Note that small precipitates of cells are visible in HSET-
overproducing YA8 cells containing 5 µM or 10 µM of AZ82. (B) Relative number of 
HSET-overproducing cells (HSEToe) in the presence of individual drugs. Cell number in 
the absence of drugs and HSEToe is set as 100%, and the relative value of individual 
conditions are calculated (n>3). All p-values are derived from the two-tailed χ2 test (**, 
P < 0.01, n.s., not significant). (C) The percentage of mitotic cells with monopolar (Mono) 
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or bipolar spindles (Bi). HSET-overproducing YA8 cells were treated with AZ82 (0, 10 
or 15 µM) for 2 d at 30°C. On the left panel, representative images of mitotic cells 
containing monopolar (top row) or bipolar cells (bottom two rows) are shown. Mitotic 
spindles were visualized with GFP-HSET, which is colocalized with spindle microtubules 
(Yukawa et al., 2018). At least >200 cells were counted. All p-values are derived from 
the two-tailed χ2 test (**, P < 0.01, ****, P < 0.0001). Scale bar, 10 µm. 
 
Fig. 5: A general strategy for identification and evaluation of specific inhibitors 
against human proteins using a fission yeast system and the detection of HSET-
inhibiting activities in extracts from plant species  
(A) Provided that human genes overexpressed in fission yeast confer some phenotype, 
such as lethality, this overproducing strain can be used as an assay system in which to 
identify specific inhibitors against these proteins. Libraries consisting of small molecules 
or natural products, or extracts prepared from Actinomycetes, marine organisms or plants 
can be used as sources of inhibitor compounds. Molecules that show activity that rescues 
lethal overproduction of protein X without any adverse off-target effects toward fission 
yeast cells would be ideal. (B) Identification of HSET-neutralizing activity in plant 
extracts. Extracts from Chamaecyparis pisifera (Sawara cypress) and Toxicodendron 
trichocarpum (Japanese sumac) were prepared in methanol (10 mg/ml) (Kimura et al., 
2012). 5 µl aliquots of extracts (each containing 0, 0.2 and 0.4 µg) were spotted onto agar 
plates. Plates were prepared from minimal media that contained HSET-overproducing 
fission yeast cells (4.6 x 104 cells/ml) and incubated at 28°C for 3 d. 
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